Comment
. 2010 Jan 12;55(2):171-2; author reply 172.
doi: 10.1016/j.jacc.2009.08.043.
Imaging surveillance for cardiovascular complications of cancer therapy
- PMID: 20117393
- DOI: 10.1016/j.jacc.2009.08.043
Item in Clipboard
Comment
Imaging surveillance for cardiovascular complications of cancer therapy
J Am Coll Cardiol.
.
Free article
No abstract available
Comment on
-
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.J Am Coll Cardiol. 2009 Jun 16;53(24):2231-47. doi: 10.1016/j.jacc.2009.02.050. J Am Coll Cardiol. 2009. PMID: 19520246 Review.
Similar articles
-
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.J Am Coll Cardiol. 2009 Jun 16;53(24):2231-47. doi: 10.1016/j.jacc.2009.02.050. J Am Coll Cardiol. 2009. PMID: 19520246 Review.
-
[Cardiovascular complications of oncological therapy].Kardiol Pol. 2004 Sep;61(9):296-9. Kardiol Pol. 2004. PMID: 15531946 Review. Polish. No abstract available.
-
[Potential use of exogenous phosphocreatine (neoton) in the combined therapy of cancer complicated with cardiovascular diseases].Vopr Onkol. 2006;52(1):112-5. Vopr Onkol. 2006. PMID: 16715719 Review. Russian. No abstract available.
-
Cardiovascular complications of breast cancer therapy.Clin Adv Hematol Oncol. 2008 Apr;6(4):247-8, 282. Clin Adv Hematol Oncol. 2008. PMID: 18496491 No abstract available.
-
Predicting and preventing the cardiotoxicity of cancer therapy.Expert Rev Cardiovasc Ther. 2008 Aug;6(7):1023-33. doi: 10.1586/14779072.6.7.1023. Expert Rev Cardiovasc Ther. 2008. PMID: 18666852 Review.
Cited by
-
Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy.Cardiol Res Pract. 2011 Mar 27;2011:378041. doi: 10.4061/2011/378041. Cardiol Res Pract. 2011. PMID: 21490697 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
